Ipg Investment Advisors LLC Oncternal Therapeutics, Inc. Transaction History

Ipg Investment Advisors LLC

  • $459 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024
BUY
$0.28 - $0.64 $6,529 - $14,924
23,319 New
23,319 $12.5 Million
Q4 2021

Feb 14, 2022
SELL
$2.27 - $4.39 $16,037 - $31,015
-7,065 Reduced 22.97%
23,691 $54,000
Q3 2021

Nov 08, 2021
SELL
$3.37 - $4.76 $1,179 - $1,666
-350 Reduced 1.13%
30,756 $128 Million
Q1 2021

May 12, 2021
BUY
$4.59 - $9.04 $142,776 - $281,198
31,106 New
31,106 $259 Million

Others Institutions Holding ONCT

# of Institutions
3
Shares Held
362K
Call Options Held
0
Put Options Held
0
View Full List

About Oncternal Therapeutics, Inc.

ONCT Quotes by TradingView
  • Ticker ONCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,517,200
  • Market Cap $29.4M
  • Description
  • Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...
More about ONCT
Track This Portfolio

Track Ipg Investment Advisors LLC Portfolio

Follow Ipg Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ipg Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ipg Investment Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email